BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26800112)

  • 1. Gal-3 does not suppress cisplatin-induced apoptosis in A-375 melanoma cells.
    Pokrywka M; Bubka M; Janik M; Pocheć E; Hoja-Łukowicz D; Lityńska A
    Cell Biol Int; 2016 Apr; 40(4):428-38. PubMed ID: 26800112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function.
    Wang D; You D; Li L
    J Toxicol Sci; 2019; 44(1):47-56. PubMed ID: 30626779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer.
    Fukumori T; Oka N; Takenaka Y; Nangia-Makker P; Elsamman E; Kasai T; Shono M; Kanayama HO; Ellerhorst J; Lotan R; Raz A
    Cancer Res; 2006 Mar; 66(6):3114-9. PubMed ID: 16540661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.
    Mourad-Zeidan AA; Melnikova VO; Wang H; Raz A; Bar-Eli M
    Am J Pathol; 2008 Dec; 173(6):1839-52. PubMed ID: 18988806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs.
    Takenaka Y; Fukumori T; Yoshii T; Oka N; Inohara H; Kim HR; Bresalier RS; Raz A
    Mol Cell Biol; 2004 May; 24(10):4395-406. PubMed ID: 15121858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
    Fukumori T; Takenaka Y; Yoshii T; Kim HR; Hogan V; Inohara H; Kagawa S; Raz A
    Cancer Res; 2003 Dec; 63(23):8302-11. PubMed ID: 14678989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.
    Hörnle M; Peters N; Thayaparasingham B; Vörsmann H; Kashkar H; Kulms D
    Oncogene; 2011 Feb; 30(5):575-87. PubMed ID: 20856198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of galectin-3 on the behavior of Eca‑109 human esophageal cancer cells.
    Liang N; Song X; Xie J; Xu D; Liu F; Yu X; Tian Y; Liu Z; Qiao L; Zhang J
    Mol Med Rep; 2015 Feb; 11(2):896-902. PubMed ID: 25373317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo galectin-3 expression influences the response of melanoma cells to isatin-Schiff base copper (II) complex-induced oxidative stimulus.
    Borges BE; Teixeira VR; Appel MH; Steclan CA; Rigo F; Filipak Neto F; da Costa Ferreira AM; Chammas R; Zanata SM; Nakao LS
    Chem Biol Interact; 2013 Oct; 206(1):37-46. PubMed ID: 23994248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions.
    Moretti D; Del Bello B; Cosci E; Biagioli M; Miracco C; Maellaro E
    Carcinogenesis; 2009 Jun; 30(6):960-7. PubMed ID: 19386580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK; Schadendorf D; Röckmann H
    Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors.
    Vereecken P; Debray C; Petein M; Awada A; Lalmand MC; Laporte M; Van Den Heule B; Verhest A; Pochet R; Heenen M
    Arch Dermatol Res; 2005 Feb; 296(8):353-8. PubMed ID: 15645276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis.
    Raffo AJ; Kim AL; Fine RL
    Oncogene; 2000 Dec; 19(54):6216-28. PubMed ID: 11175336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of different sequences of radio- and chemotherapy in experimental models of human melanoma.
    Arienti C; Zoli W; Pignatta S; Carloni S; Paganelli G; Ulivi P; Romeo A; Menghi E; Sarnelli A; Medri L; Polico R; Silvestrini R; Tesei A
    J Cell Physiol; 2014 Oct; 229(10):1548-56. PubMed ID: 24591063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity.
    Radosavljevic G; Jovanovic I; Majstorovic I; Mitrovic M; Lisnic VJ; Arsenijevic N; Jonjic S; Lukic ML
    Clin Exp Metastasis; 2011 Jun; 28(5):451-62. PubMed ID: 21442355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the nuclear import pathways of galectin-3.
    Nakahara S; Oka N; Wang Y; Hogan V; Inohara H; Raz A
    Cancer Res; 2006 Oct; 66(20):9995-10006. PubMed ID: 17047062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells.
    Harazono Y; Kho DH; Balan V; Nakajima K; Zhang T; Hogan V; Raz A
    Oncotarget; 2014 Oct; 5(20):9992-10001. PubMed ID: 25393982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
    Lesiak K; Koprowska K; Zalesna I; Nejc D; Düchler M; Czyz M
    Melanoma Res; 2010 Feb; 20(1):21-34. PubMed ID: 19949351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.